novartis glp-1 use tripled among non-diabetics, reaching $5.8B in 2022 Novartis divulges new GLP-1R agonists

Aiad AAE, El-Haggar SM, El-Barbary AM, El-Afify DR

Controlled preparation workflows

Withdrawal Period Meat: Animals must not be slaughtered for human consumption within 21 days of administration

2017 Cell study used 5 mg/kg intraperitoneal injection three times per week in aged mice, with treatment periods of several weeks the three-times-weekly dosing suggests the peptide maintains sufficient functional concentrations for at least 48-72 hours per dose (PMID: 28340339)

Eur J Neurosci 2005, 22, (8), 194250, Sontag, E

A qualitative distinction exists between (difficult to stimulate/afferently acting) naive and (easy to stimulate/efferently acting) effector/memory cells